Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]
Xeltis has announced successful clinical data from its aXess EU [...]
Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]
Xeltis has announced successful clinical data from its aXess EU [...]